UFP Technologies (UFPT) has attracted attention after recent trading, with the stock last closing at $239.28. For investors, the key question is how current pricing lines up with its fundamentals and recent returns.

The recent 5.09% 1 day share price return at UFP Technologies adds to a 26.76% 90 day share price return, while the 5 year total shareholder return of 310.29% points to a strong longer term payoff profile.

If you are comparing UFP Technologies with other areas of the market, this could be a good moment to scan for opportunities in 40 healthcare AI stocks

With UFP Technologies trading at $239.28 and sitting at a reported 34.8% discount to one estimate of intrinsic value, the key question is whether this signals an undervalued stock or if the market is already pricing in future growth.

Price-to-Earnings of 27x: Is it justified?

On a simple earnings lens, UFP Technologies currently trades on a P/E of 27x, which sits above both its own fair ratio estimate and the wider US medical equipment peer group.

The P/E multiple compares the current share price with earnings per share and is a common way investors think about how much they are paying for each dollar of profit. For a company like UFP Technologies, which operates across medical devices, sterile packaging and other engineered products, this lens helps frame how the market is weighing its earnings profile against other healthcare suppliers.

Here, the stock trades at 27x earnings compared with an estimated fair P/E of 22.1x. The market could move toward that level if sentiment or expectations cool. It also sits above the US Medical Equipment industry average P/E of 24.4x, which points to investors currently paying a premium versus the broader sector for each dollar of UFPT earnings.

Result: Price-to-Earnings of 27x (OVERVALUED).

However, UFP Technologies still faces risks around its premium P/E rating compressing if medical demand softens or if its 6.17% revenue growth pace slows materially.

Another view on UFP Technologies’ valuation

While the 27x P/E suggests UFP Technologies is priced at a premium, the SWS DCF model presents a different perspective. On that approach, the stock at $239.28 is compared with an estimated future cash flow value of $366.92, which screens as undervalued. Which lens do you consider more useful for a long term view?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out UFP Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 45 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mix of positives and concerns around UFP Technologies, it makes sense to review the underlying data yourself and move quickly from headline impressions to your own judgment. To see how the trade off between risk and reward stacks up in more detail, take a closer look at the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond UFP Technologies?

If UFP Technologies has caught your attention, do not stop there. Use the Simply Wall St Screener to compare it with other opportunities and sharpen your watchlist.

• Spot potential mispricings early by reviewing companies screened as 45 high quality undervalued stocks before they attract wider interest.
• Prioritise resilience by focusing on businesses highlighted in the 65 resilient stocks with low risk scores so you are not relying on just one stock story.
• Hunt for future standouts by scanning the screener containing 19 high quality undiscovered gems and see which lesser known companies fit your criteria.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.